The
The Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) is a leading research institute in Germany that has specialized in the biomedical study of human aging since its founding in 2004. With about 300 employees, including researchers from over 30 countries, the FLI is an international center for aging research.
The main mission of the FLI is to decipher the molecular mechanisms of aging and to develop new therapies that reduce the risk of age-related diseases such as cancer. The institute places great importance on collaboration between scientists from various disciplines to create the foundations for a healthier lifespan in old age.
The FLI is committed to family-friendly working conditions and has been awarded the Jena Family Seal multiple times. This award recognizes the institute's commitment to flexible working hours, childcare options, and support for reintegration after family phases. Additionally, the FLI promotes digitalization in its administration to ensure more efficient processes.
The FLI is involved in various international research projects, including studies on the evolution of sperm lengths in tetrapods. These works demonstrate the diversity and depth of research at the FLI and highlight the importance of interdisciplinary approaches in aging research.